Lotensin Hct Tablet
Product Images NDC 30698-452

5 FDA label images from Validus Pharmaceuticals Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lotensin Hct (NDC 30698-452). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Validus Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Benazepril Hydrochloride Structural Formula. (Lotensin Hct 01)

Benazepril Hydrochloride Structural Formula. (Lotensin Hct 01)
Chemical structure diagram of benazepril hydrochloride, the active ingredient in Lotensin HCT tablets, depicting its molecular components and hydrochloride salt form.*
FDA Label Image

Hydrochlorothiazide Structural Formula. (Lotensin Hct 02)

Hydrochlorothiazide Structural Formula. (Lotensin Hct 02)
Chemical structure diagram of benazepril hydrochloride, showing its molecular arrangement with labeled atoms including sulfur, oxygen, nitrogen, chlorine, and a benzene ring.*
FDA Label Image

Principal Display Panel 10 mg Benazepril/12.5 mg Hydrochlorothiazide Tabletndc 30698-452-01lotensin Hct® Benazepril HCl Usp 10 mghydrochlorothiazide Usp 12.5 mg10/12.5 100 Tabletsrx Only (Lotensin Hct 03)

Principal Display Panel 10 mg Benazepril/12.5 mg Hydrochlorothiazide Tabletndc 30698-452-01lotensin Hct® Benazepril HCl Usp 10 mghydrochlorothiazide Usp 12.5 mg10/12.5 100 Tabletsrx Only (Lotensin Hct 03)
Lotensin HCT 10 mg/12.5 mg oral tablet carton label from Validus Pharmaceuticals LLC. The label shows the proprietary name, active ingredients benazepril HCl and hydrochlorothiazide with their strengths, package count of 100 tablets, and the NDC number 30698-452-01. The label includes dosage storage instructions and a barcode.*
FDA Label Image

Principal Display Panel 20 mg Benazepril/12.5 mg Hydrochlorothiazide Tabletndc 30698-453-01lotensin Hct® 20/12.5benazepril HCl Usp 20 mghydrochlorothiazide Usp 12.5 mg20/12.5100 Tabletsrx Only (Lotensin Hct 04)

Principal Display Panel 20 mg Benazepril/12.5 mg Hydrochlorothiazide Tabletndc 30698-453-01lotensin Hct® 20/12.5benazepril HCl Usp 20 mghydrochlorothiazide Usp 12.5 mg20/12.5100 Tabletsrx Only (Lotensin Hct 04)
Lotensin HCT 20 mg / 12.5 mg oral tablet label from Validus Pharmaceuticals LLC. The label shows the active ingredients benazepril hydrochloride USP 20 mg and hydrochlorothiazide USP 12.5 mg. The package contains 100 tablets and includes NDC 30698-453-01 with storage and handling instructions.*
FDA Label Image

Principal Display Panel 20 mg Benazepril/25 mg Hydrochlorothiazide Tabletndc 30698-454-01lotensin Hct® 20/25benazepril HCl Usp 20 mghydrochlorothiazide Usp 25 mg20/25100 Tabletsrx Only (Lotensin Hct 05)

Principal Display Panel 20 mg Benazepril/25 mg Hydrochlorothiazide Tabletndc 30698-454-01lotensin Hct® 20/25benazepril HCl Usp 20 mghydrochlorothiazide Usp 25 mg20/25100 Tabletsrx Only (Lotensin Hct 05)
Lotensin HCT 20 mg benazepril hydrochloride and 25 mg hydrochlorothiazide oral tablets label. The label indicates a package of 100 tablets by Validus Pharmaceuticals LLC with dosage and storage instructions. The NDC code 30698-454-01 and bar code are visible on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.